Adis Journals
Browse
Summary Slide.png (125.32 kB)

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients With Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Download (125.32 kB)
media
posted on 2020-11-24, 15:11 authored by Michael Willis, Andreas Nilsson, Klas Kellerborg, Philip Ball, Rupert Roe, Shana Traina, Rebecca Beale, Isabelle Newell

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Diabetes Therapy

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC